DepoMed, Inc. (NASDAQ: DEPO) reported Q4 EPS of ($0.25), $0.04 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $12.1 million versus the consensus estimate of $10.88 million.

For earnings history and earnings-related data on DepoMed, Inc. (DEPO) click here.

Earnings